Shares of Cansortium Inc. (OTCMKTS:CNTMF – Get Rating) traded down 9.1% during trading on Wednesday . The company traded as low as $0.12 and last traded at $0.13. 111,050 shares traded hands during trading, a decline of 6% from the average session volume of 117,983 shares. The stock had previously closed at $0.14.
Analyst Ratings Changes
Separately, BTIG Research assumed coverage on shares of Cansortium in a research note on Friday, October 28th. They set a “buy” rating on the stock.
Cansortium Stock Performance
The business’s 50 day simple moving average is $0.14 and its 200 day simple moving average is $0.16.
Cansortium Company Profile
Cansortium, Inc engages in the production and sale of medical cannabis. The firm focuses on oil extracted and derived products for use by medical patients. Its objective is to invest in and develop multiple jurisdictions for the vertical integrated approach for the sale and distribution of processed cannabis oil in medical use frameworks.
Recommended Stories
- Get a free copy of the StockNews.com research report on Cansortium (CNTMF)
- CVS Health Corporation Is Coiled And Ready To Spring Higher
- Will The Pullback In Paycom Payoff For Investors?
- TJX Among Apparel Retailers All Dressed Up & Ready For Growth
- Daqo New Energy Charged Up For New Highs
- No Spice In Chipotle Results, Is Now The Time To Buy?
Receive News & Ratings for Cansortium Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cansortium and related companies with MarketBeat.com's FREE daily email newsletter.
